Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Disposal Update

1st Apr 2016 07:00

RNS Number : 8063T
UDG Healthcare Public Limited Co.
01 April 2016
 

 

1 April 2016

 

UDG Healthcare PLC

Disposal Update

 

UDG Healthcare plc ("the Company") can confirm that further to the announcements on 18 September 2015, 13 October 2015 and 4 March 2016, the Company has today completed the disposal of its United Drug Supply Chain and MASTA businesses to McKesson Corporation and Celesio Group.

 

For further information, please contact:

 

Investors and Analysts:

Alan Ralph

CFO

UDG Healthcare plc

Tel: +353-1-463-2300

 

 

Keith Byrne

Head of Investor Relations and Strategy

UDG Healthcare plc

Tel: + 353-1-463-7722

 

Media:

Business / Financial media:

Lisa Kavanagh / Jack Hickey

Powerscourt

Tel: +44-207-250-1446

 

 

About UDG Healthcare plc:

 

UDG Healthcare plc (LON: UDG) is a leading international provider of services to the healthcare industry, employing over 7,000 employees at operations across 19 countries including the US, UK, Ireland and Germany.

 

UDG Healthcare plc operates across three divisions: Ashfield Commercial & Medical Services, Sharp Packaging Services and Supply Chain Services.

 

Ashfield Commercial & Medical Services is a global leader in the provision of sales, marketing and healthcare communications services to pharmaceutical companies. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle enabling improved compliance and clinical outcomes. The division provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in 18 countries.

 

Sharp Packaging Services is a global leader in contract packaging and clinical trial packaging services for the pharmaceutical and biotechnology industries, operating from state of the art facilities across the US and Europe. Sharp is also a world leader in 'Track and Trace' serialisation services, which will require all prescription drugs to have a unique serial code for authentication and traceability.

 

Supply Chain Services consists of Aquilant, a leading provider of outsourced sales, marketing, distribution and engineering services to the medical and scientific sectors in the UK, Ireland and the Netherlands.

 

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250.

For more information please go to: www.udghealthcare.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISSDEEDFFMSEED

Related Shares:

UDG.L
FTSE 100 Latest
Value8,275.66
Change0.00